US$ 22.81
glp-1 pregnancy risk receptor agonists are increasingly used before pregnancy, but safety data have been limited., This meta-analysis pooled data from nearly 37,000 pregnancies and found no increased of major GLP-1 Medications and Pregnancy: When
Description
The primary endpoint in the CV safety outcome trials was a composite of CV death, non-fatal myocardial infarct, and non-fatal stroke (and unstable angina requiring hospitalization in TECOS)

P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., & Hartman, M

Its also a personal decision based on your own preferences

We do not have good data to say X type of exercise or amount is going to give the best results, Shah said
Berberine vs

The researchers note that further analyses are planned to address some of these variables